Nicole Paulk Email

CEO, Founder, President . Siren Biotechnology

Current Roles

Employees:
11
Revenue:
$1.7M
About
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy.\nWe are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
Siren Biotechnology Address

San Francisco, CA
United States
Siren Biotechnology Email